» Articles » PMID: 28830564

Availability of Healthcare Resources and Epithelial Ovarian Cancer Stage of Diagnosis and Mortality Among Blacks and Whites

Overview
Journal J Ovarian Res
Publisher Biomed Central
Date 2017 Aug 24
PMID 28830564
Citations 13
Authors
Affiliations
Soon will be listed here.
Abstract

Background: The purpose of this study is to examine whether racial disparities in epithelial ovarian cancer stage at diagnosis and survival may be explained by geographic availability of healthcare resources among Blacks and Whites.

Methods: Data from the Surveillance, Epidemiology and End Results (SEER) database was used to identify White and Black women ages 40 years and above diagnosed with epithelial ovarian cancer between 2000 and 2010. Data on county-level availability of healthcare resources was obtained from the Area Resource File. Multi-level regression models, overall and stratified by race and age, were used to examine the associations of health care access (HCA) and socioeconomic status (SES) with stage at diagnosis while Cox proportional hazards models were used to examine the association with survival.

Results: Among 46,423 women diagnosed with epithelial ovarian cancer, Blacks were more likely to reside in counties with fewer average number of oncology hospitals (p < 0.05) and hospitals with ultrasound (p < 0.001), but higher number of medical doctors (p < 0.0001) and Ob/Gyn (p < 0.001). Black patients had higher odds of late stage diagnosis of epithelial ovarian cancer (OR: 1.13, 95% CI: 1.04-1.25) and higher risk of epithelial ovarian cancer mortality (HR: 1.25, 95% CI: 1.19-1.32) compared with White patients after accounting for differential availability of healthcare resources. Among Black patients, residing in counties with fewer medical doctors was associated with increased odds of late stage diagnosis (OR: 1.86, 95% CI: 1.10-3.13), and the racial disparity in late stage diagnosis and mortality was larger among patients ages <65 years compared with older patients.

Conclusion: Racial disparities in availability and utilization of healthcare resources likely contributes to adverse epithelial ovarian cancer outcomes among Black women in the US.

Citing Articles

Predicting Survival Outcomes for Patients with Ovarian Cancer Using National Cancer Registry Data from Taiwan: A Retrospective Cohort Study.

Chattopadhyay A, Wu Y, Chan H, Kang Y, Chiang Y, Chiang C Womens Health Rep (New Rochelle). 2025; 6(1):90-101.

PMID: 39882147 PMC: 11773178. DOI: 10.1089/whr.2024.0166.


Stage IV ovarian cancer prognosis nomogram and analysis of racial differences: A study based on the SEER database.

Wu G, Chen J, Niu P, Huang X, Chen Y, Zhang J Heliyon. 2024; 10(16):e36549.

PMID: 39262992 PMC: 11388394. DOI: 10.1016/j.heliyon.2024.e36549.


Racial and socioeconomic disparities in survival among women with advanced-stage ovarian cancer who received systemic therapy.

Washington C, Karanth S, Wheeler M, Aduse-Poku L, Braithwaite D, Akinyemiju T Cancer Causes Control. 2023; 35(3):487-496.

PMID: 37874478 PMC: 10838826. DOI: 10.1007/s10552-023-01810-y.


Unique Considerations in Early Detection, Risk, and Awareness of Endometrial Cancer in Black Women.

Schlumbrecht M, Wright K, George S Cancer Control. 2023; 30:10732748231202952.

PMID: 37732413 PMC: 10515581. DOI: 10.1177/10732748231202952.


Health Disparities in Ovarian Cancer: Report From the Ovarian Cancer Evidence Review Conference.

Mei S, Chelmow D, Gecsi K, Barkley J, Barrows E, Brooks R Obstet Gynecol. 2023; 142(1):196-210.

PMID: 37348095 PMC: 10278570. DOI: 10.1097/AOG.0000000000005210.


References
1.
Prat J . Staging classification for cancer of the ovary, fallopian tube, and peritoneum. Int J Gynaecol Obstet. 2013; 124(1):1-5. DOI: 10.1016/j.ijgo.2013.10.001. View

2.
Moorman P, Palmieri R, Akushevich L, Berchuck A, Schildkraut J . Ovarian cancer risk factors in African-American and white women. Am J Epidemiol. 2009; 170(5):598-606. PMC: 2732987. DOI: 10.1093/aje/kwp176. View

3.
Akinyemiju T, Moore J, Altekruse S . Breast cancer survival in African-American women by hormone receptor subtypes. Breast Cancer Res Treat. 2015; 153(1):211-8. PMC: 6043784. DOI: 10.1007/s10549-015-3528-7. View

4.
Barnholtz-Sloan J, Schwartz A, Qureshi F, Jacques S, Malone J, Munkarah A . Ovarian cancer: changes in patterns at diagnosis and relative survival over the last three decades. Am J Obstet Gynecol. 2003; 189(4):1120-7. DOI: 10.1067/s0002-9378(03)00579-9. View

5.
Bandera E, Lee V, Rodriguez-Rodriguez L, Powell C, Kushi L . Racial/Ethnic Disparities in Ovarian Cancer Treatment and Survival. Clin Cancer Res. 2016; 22(23):5909-5914. PMC: 5135649. DOI: 10.1158/1078-0432.CCR-16-1119. View